NM_001110792.2:c.*544G>A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_001110792.2(MECP2):​c.*544G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00213 in 148,289 control chromosomes in the GnomAD database, including 1 homozygotes. There are 90 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0020 ( 1 hom., 65 hem., cov: 23)
Exomes 𝑓: 0.0024 ( 0 hom. 25 hem. )

Consequence

MECP2
NM_001110792.2 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter U:1B:1

Conservation

PhyloP100: -1.07

Publications

0 publications found
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
MECP2 Gene-Disease associations (from GenCC):
  • chromosome Xq28 duplication syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • Rett syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, G2P
  • severe neonatal-onset encephalopathy with microcephaly
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • syndromic X-linked intellectual disability Lubs type
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked intellectual disability-psychosis-macroorchidism syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant X-154029823-C-T is Benign according to our data. Variant chrX-154029823-C-T is described in ClinVar as Benign. ClinVar VariationId is 143276.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00204 (230/112529) while in subpopulation AMR AF = 0.00326 (35/10736). AF 95% confidence interval is 0.00241. There are 1 homozygotes in GnomAd4. There are 65 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 230 XL,Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MECP2NM_001110792.2 linkc.*544G>A 3_prime_UTR_variant Exon 3 of 3 ENST00000453960.7 NP_001104262.1
MECP2NM_004992.4 linkc.*544G>A 3_prime_UTR_variant Exon 4 of 4 ENST00000303391.11 NP_004983.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MECP2ENST00000453960.7 linkc.*544G>A 3_prime_UTR_variant Exon 3 of 3 1 NM_001110792.2 ENSP00000395535.2
MECP2ENST00000303391.11 linkc.*544G>A 3_prime_UTR_variant Exon 4 of 4 1 NM_004992.4 ENSP00000301948.6
MECP2ENST00000630151.3 linkc.*544G>A 3_prime_UTR_variant Exon 4 of 4 5 ENSP00000486089.2

Frequencies

GnomAD3 genomes
AF:
0.00204
AC:
230
AN:
112477
Hom.:
1
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00139
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00326
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00167
Gnomad SAS
AF:
0.00219
Gnomad FIN
AF:
0.000806
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00250
Gnomad OTH
AF:
0.00132
GnomAD4 exome
AF:
0.00240
AC:
86
AN:
35760
Hom.:
0
Cov.:
0
AF XY:
0.00307
AC XY:
25
AN XY:
8152
show subpopulations
African (AFR)
AF:
0.00173
AC:
2
AN:
1156
American (AMR)
AF:
0.00378
AC:
10
AN:
2649
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
737
East Asian (EAS)
AF:
0.000865
AC:
2
AN:
2313
South Asian (SAS)
AF:
0.00317
AC:
11
AN:
3472
European-Finnish (FIN)
AF:
0.000753
AC:
1
AN:
1328
Middle Eastern (MID)
AF:
0.0116
AC:
1
AN:
86
European-Non Finnish (NFE)
AF:
0.00242
AC:
54
AN:
22280
Other (OTH)
AF:
0.00288
AC:
5
AN:
1739
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.544
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00204
AC:
230
AN:
112529
Hom.:
1
Cov.:
23
AF XY:
0.00187
AC XY:
65
AN XY:
34691
show subpopulations
African (AFR)
AF:
0.00139
AC:
43
AN:
30981
American (AMR)
AF:
0.00326
AC:
35
AN:
10736
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2650
East Asian (EAS)
AF:
0.00168
AC:
6
AN:
3577
South Asian (SAS)
AF:
0.00220
AC:
6
AN:
2732
European-Finnish (FIN)
AF:
0.000806
AC:
5
AN:
6204
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.00250
AC:
133
AN:
53208
Other (OTH)
AF:
0.00130
AC:
2
AN:
1533
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000487
Hom.:
2
Bravo
AF:
0.00202

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Autism, susceptibility to, X-linked 3 Uncertain:1
Nov 01, 2007
RettBASE
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:curation

- -

Rett syndrome Benign:1
Aug 14, 2023
Centre for Population Genomics, CPG
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria.Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders to the ACMG/AMP Variant Interpretation Guidelines VCEP 2.0 , this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 2.0 (BA1). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.28
DANN
Benign
0.66
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs183349022; hg19: chrX-153295274; API